Does ENZALUTAMIDE Cause Electrocardiogram qt prolonged? 115 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 115 reports of Electrocardiogram qt prolonged have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
115
Reports of Electrocardiogram qt prolonged with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
9
Deaths
59
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From ENZALUTAMIDE?
Of the 115 reports, 9 (7.8%) resulted in death, 59 (51.3%) required hospitalization, and 24 (20.9%) were considered life-threatening.
Is Electrocardiogram qt prolonged Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 115 reports have been filed with the FAERS database.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which ENZALUTAMIDE Alternatives Have Lower Electrocardiogram qt prolonged Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE